** Shares of CSPC Pharmaceutical Group 1093.HK jump 12.3% to HK$8.56, their highest since March 2023
** Stock set for the biggest one-day pct rise since November 2022; top pct gainer in the Hang Seng Index .HSI
** CSPC said it is in negotiations with independent third parties on three transactions involving license, collaboration in development, manufacturing and commercialization of certain products with upfront payments amounting to an aggregate $5 bln
** Hong Kong's healthcare index .HSCIH climbs 0.5%, Hang Seng Biotech Index .HSHKBIO gains 0.8%
** YTD, stock up 72.4%
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.